Citalopram hydrobromide and Aplastic anemia - a phase IV clinical study of FDA data

Summary:

Aplastic anemia is reported as a side effect among people who take Citalopram hydrobromide (citalopram hydrobromide), especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years also take Tegretol, and have Epilepsy.

The phase IV clinical study analyzes which people have Aplastic anemia when taking Citalopram hydrobromide. It is created by eHealthMe based on reports of 32,819 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,878 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Aplastic anemia?

Aplastic anemia is found to be associated with 626 drugs and 879 conditions by eHealthMe. Check the latest studies of Aplastic anemia.

On Jul, 17, 2026

32,819 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 18 people (0.05%) have Aplastic anemia.

Could Citalopram hydrobromide cause Aplastic anemia?

Among these 18 people:

How long have people been on Citalopram hydrobromide when they have Aplastic anemia? *

What is the gender of people who have Aplastic anemia when taking Citalopram hydrobromide? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Aplastic anemia when taking Citalopram hydrobromide? *

What are other drugs people take besides Citalopram hydrobromide? *

What are other side effects people have besides Aplastic anemia? *

Vaginal Bleeding: 8 people, 44.44%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 22.22%
Arrhythmias (irregular heartbeat): 3 people, 16.67%
Mucosal Inflammation (infection of mucous membrane): 3 people, 16.67%
Acute Myocardial Infarction (acute heart attack): 3 people, 16.67%
Thrombocytopenia (decrease of platelets in blood): 3 people, 16.67%
Nausea (feeling of having an urge to vomit): 3 people, 16.67%
Weight Loss: 2 people, 11.11%
Paleness (unusual lightness of skin colour): 2 people, 11.11%
Pain In Extremity: 2 people, 11.11%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 7 people, 38.89%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 27.78%
Weight Loss: 2 people, 11.11%
Prostate Cancer Metastatic: 2 people, 11.11%
Prostate Cancer: 2 people, 11.11%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Dyspnea (difficult or laboured breathing): 2 people, 11.11%
Acute Myocardial Infarction (acute heart attack): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and have Aplastic anemia?

- Check whether Aplastic anemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Citalopram hydrobromide:

Citalopram hydrobromide (36,878 reports)

Aplastic anemia treatments and more:

Aplastic anemia (14,870 reports)

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aplastic anemia:

Aplastic anemia (626 drugs)

Browse all the conditions that are associated with Aplastic anemia:

Aplastic anemia (879 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.